Reviewed explainer
A hallmark is a way of organising aging biology. It is not a diagnosis, a personal score or a promise that changing one pathway will make a person live longer. The influential 2013 framework proposed nine tentative hallmarks. Its 2023 update proposed twelve, adding disabled macroautophagy, chronic inflammation and dysbiosis as distinct entries.1, 2
Geroprotect uses those twelve together with two clearly labelled emerging extensions—RNA-splicing dysregulation and age-related tissue or extracellular-matrix stiffening—as a practical 14-part educational map. That 12 + 2 distinction matters: the extra two have a real scientific literature, but they are not part of the canonical twelve proposed in the 2023 Cell paper.
01 · The framework
From nine to twelve
The original hallmarks paper was powerful because it turned a crowded field into a testable map. It grouped aging mechanisms into nine categories: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem-cell exhaustion and altered intercellular communication.1
A decade of research did not make that list obsolete; it made several previously embedded processes important enough to stand alone. The 2023 update proposed twelve hallmarks:2
| Hallmark | Plain-language role |
|---|---|
| Genomic instability | Damage and errors accumulate in nuclear and mitochondrial DNA. |
| Telomere attrition | Chromosome-end structures shorten or become dysfunctional in relevant dividing cells. |
| Epigenetic alterations | Gene-regulating marks and chromatin organisation change with age. |
| Loss of proteostasis | Protein production, folding, repair and disposal become less reliable. |
| Disabled macroautophagy | A major cellular recycling route becomes less effective. |
| Deregulated nutrient sensing | Growth, energy and stress-response networks become misaligned. |
| Mitochondrial dysfunction | Cellular energy systems and mitochondrial signalling change. |
| Cellular senescence | Some stress-damaged cells enter a persistent non-dividing state and alter their surroundings. |
| Stem-cell exhaustion | Tissue-renewal capacity declines in some stem and progenitor compartments. |
| Altered intercellular communication | Signals between cells, tissues and organs lose coordination. |
| Chronic inflammation | Persistent low-grade inflammatory signalling becomes more common with age. |
| Dysbiosis | Host-associated microbial communities and their interactions with the host shift. |
02 · A network, not fourteen boxes
Why the arrows between hallmarks matter
The list is easiest to remember as boxes, but biology behaves like a network. DNA damage can promote cellular senescence. Senescent cells can alter inflammatory and tissue signals. Mitochondrial dysfunction can affect energy availability, redox signalling and innate immune activity. Disabled autophagy can worsen protein and organelle quality, which may feed back into mitochondrial stress.
This interconnectedness creates two common errors. The first is to count how many hallmarks a compound touches in a cell experiment and treat the total as an efficacy score. The second is to assume that more ingredients automatically produce broader or stronger human effects. Neither follows. A pathway can be influenced in the wrong tissue, at an irrelevant exposure, or without improving a meaningful outcome. Interactions can also be neutral, redundant or context-dependent.
The framework is most useful for asking better questions: What model was studied? Was the hallmark measured directly or inferred from a biomarker? Did the intervention improve function? Was the experiment in cells, an animal or people? Those questions turn a diagram into an evidence tool.
03 · The emerging two
RNA splicing and tissue mechanics deserve attention—with the label intact
RNA-splicing dysregulation
Before many genes become proteins, their RNA transcripts must be cut and assembled. Splicing-factor expression and alternative-splicing patterns change with age in multiple tissues. In one human-fibroblast study, small molecules altered splicing-factor expression alongside several features of cellular senescence.3 That is useful mechanistic evidence, but it is a cell experiment: it does not establish that a supplement corrects splicing in an aging person or improves a clinical outcome.
Extracellular-matrix and tissue stiffening
Cells do not age in isolation. They live inside a structural and mechanical environment. Work in aged skeletal muscle found that extracellular-matrix changes and greater tissue stiffness could redirect muscle stem cells toward a more fibrogenic state.4 Human vascular samples and cell-derived matrices have also linked senescence, matrix composition and stiffness in a reinforcing loop.5
These findings justify treating mechanics as more than background scenery. They do not yet make “tissue stiffening” a universally agreed thirteenth or fourteenth hallmark. Geroprotect therefore names both mechanisms as emerging extensions rather than quietly changing the canonical framework.
04 · Formula context
What an ingredient map can honestly say
Geroprotect’s Science page uses the 12 + 2 map to show why particular ingredients entered the research conversation. That is formulation rationale. It is not evidence that Essentials I, Essentials II or the two-formula combination modifies fourteen hallmarks in humans.
The distinction is especially important for isolated-ingredient studies. Evidence may involve a different chemical form, dose, population, duration or endpoint from the current product. Findings from cells and animals are valuable for mechanism discovery, but they cannot establish a human outcome. The complete formulas have not been tested in a controlled clinical trial against their individual components.
Customers can inspect every current ingredient and labelled amount on the Formula page. The Science section carries the deeper literature because a shopping page and an evidence review serve different jobs.
Evidence verdict
A map that should keep changing
The twelve-hallmark framework is a respected synthesis, not a final law of biology. It has already expanded once, and new mechanisms will continue to compete for inclusion. The responsible approach is to keep the canonical list visible, label extensions, and resist turning pathway coverage into a product score. The map helps organise evidence; the evidence still has to be read.
Questions
Frequently asked questions
Are there nine, twelve or fourteen hallmarks of aging?
The original 2013 paper proposed nine. The same authors proposed twelve in their 2023 update. Geroprotect displays those twelve plus two published emerging mechanisms—splicing dysregulation and tissue stiffening—as a clearly labelled 12 + 2 educational map.
Does covering more hallmarks make a formula better?
Not automatically. A pathway connection does not establish adequate exposure, a beneficial human effect or a useful combination. Quality, dose, study design, population and meaningful outcomes matter more than a count.
Can a blood test measure all the hallmarks?
No validated single test measures every hallmark across the body. Individual biomarkers may reflect parts of the biology, but tissues age differently and many measurements remain research tools rather than personal clinical scores.
Primary and framework sources
References
- López-Otín C, et al. The hallmarks of aging. Cell. 2013;153:1194–1217. PMID 23746838.
- López-Otín C, et al. Hallmarks of aging: An expanding universe. Cell. 2023;186:243–278. PMID 36599349.
- Latorre E, et al. Small molecule modulation of splicing factor expression is associated with rescue from cellular senescence. BMC Cell Biology. 2017;18:31. PMID 29041897.
- Stearns-Reider KM, et al. Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion. Aging Cell. 2017;16:518–528. PMID 28371268.
- Faleeva M, et al. Sox9 accelerates vascular aging by regulating extracellular matrix composition and stiffness. Circulation Research. 2024;134:307–324. PMID 38179698.










